Cross-Modal Imaging in Noninvasive Identification of Histologic Features of Skin
The results of this study suggest the safety of cross-modal imaging and that trained physicians may accurately identify histologic features on cross-modal images, consistent with its US Food and Drug Administration-cleared role in assisting clinical judgment.
Authors
- David Pilkington
- Lilia Correa‐Selm (ORCID: https://orcid.org/0000-0001-6289-0465)
- Manu Jain (ORCID: https://orcid.org/0000-0003-1534-5629)
- Michael Z. Wang (ORCID: https://orcid.org/0000-0001-8253-3262)
- Sarah T. Arron (ORCID: https://orcid.org/0000-0001-5669-0627)
- Afton Cobb
- Jennifer Y. Wang (ORCID: https://orcid.org/0000-0002-2537-1081)
- Kenna S. Given
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of California, San Francisco (US)
- University of South Florida (US)
- Moffitt Cancer Center (US)
- Meta (United States) (US)
- Palo Alto Institute (US)
- Golden Valley Health Centers (US)
- Advanced Dermatology (US)
- Stanford University (US)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1001/jamadermatol.2025.4318
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00